Related Experiment Video
Updated: May 5, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Percutaneous left atrial appendage closure for stroke prevention: current challenges and future perspectives
Carla Rochira1, Alessandro Mazzapicchi2, Salvatore Davide Tomasello3
1Division of Cardiology, Azienda Ospedaliero-Universitaria Policlinico "G. Rodolico - San Marco", University of Catania, Catania, Italy.
Percutaneous left atrial appendage closure (LAAC) offers stroke prevention for patients with atrial fibrillation unsuitable for anticoagulation. This review examines LAAC
Area of Science:
- Cardiology
- Medical Devices
- Stroke Prevention
Background:
- Stroke is a leading cause of death and disability globally.
- Non-valvular atrial fibrillation increases stroke risk.
- Oral anticoagulation is standard but not always feasible.
Purpose of the Study:
- To review the current state of percutaneous left atrial appendage closure (LAAC).
- To identify challenges and unmet needs in LAAC.
- To provide an updated perspective on this stroke prevention strategy.
Main Methods:
- Review of current literature and clinical data on LAAC.
- Analysis of approved and investigational LAAC devices.
- Discussion of evidence, adverse events, and post-procedural therapy.
Main Results:
- LAAC is a developing field with multiple device options.
- Key challenges include limited high-quality evidence and late adverse events.
- Uncertainty exists regarding optimal post-procedural antithrombotic therapy.
Conclusions:
- Percutaneous LAAC is a significant alternative for stroke prevention in specific patient groups.
- Further research is needed to address current limitations and optimize patient outcomes.
- The field requires more robust evidence and standardized protocols.
Related Concept Videos
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Mitral Regurgitation I: Introduction
Aortic Regurgitation III: Medical Management
Introduction Cardiac Emergencies
Heart Failure III: Clinical Manifestations
Cardiomyopathy III: Hypertrophic Cardiomyopathy

